Heartseed Inc.

PR

PR Notice of Approval for Listing on the Growth Market of the Tokyo Stock Exchange

PR Heartseed.'s CFO, Mutsuki Takano, Named "Most Innovative CFO from Asia to Watch in 2024" by CXO Magazine

PR Prof. Massimiliano Gnecchi, Renowned Translational Cardiology Expert, Delivers Lecture at Heartseed.

PR Heartseed CEO Keiichi Fukuda Wins Japanese Society for Regenerative Medicine "Achievement Award"

PR Heartseed CEO Keiichi Fukuda Delivers Keynote on Regenerative Medicine at aichung Veterans General Hospital in Taiwan

PR Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

PR Heartseed Announces the Presentation of HS-001, an Investigational Stem Cell-Derived Therapy for the Treatment of Advanced Heart Failure at the 71st Annual Meeting of the Japanese College of Cardiology

PR Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy

PR Heartseed Announces Positive 26-week Data for the First Patient in the Phase 1/2 Clinical Trial (LAPiS Study) Dosed With HS-001, an Investigational Stem Cell-Derived Therapy for the Treatment of Advanced Heart Failure

PR Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure

1 2 3 4